# TVRD (Tvardi Therapeutics, Inc.) - SEC EDGAR Financial Statements

> Tvardi Therapeutics, Inc. reported $23.53M in total assets and a net loss of $26.66M through December 31, 2025 from SEC EDGAR filings.

- Canonical: https://convexityos.com/fundamentals/TVRD
- Markdown: https://convexityos.com/fundamentals/TVRD.md
- SEC CIK: 0001346830
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 21, 2026, 05:04 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001346830&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | -- | Dec 31, 2025 |
| Operating Income | FY 2025 | -$27.59M | Operating profit |
| Net Income | FY 2025 | -$26.66M | GAAP bottom line |
| Diluted EPS | FY 2025 | -$2.11 | Split-adjusted |
| Free Cash Flow | FY 2025 | -- | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $22.27M | Total debt: $116K |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | -- | $7.14M | $20.97M | $41.87M | $23.03M | $135.1M | $19.89M | $13.47M | $911K | $86K |
| Cost of Revenue | -- | -- | -- | -- | $0 | -- | -- | -- | -- | -- |
| **Gross Profit** | -- | -- | -- | -- | $23.03M | -- | -- | -- | -- | -- |
| Research & Development | $18.01M | $23.65M | $108.5M | $91.88M | $82.70M | $107.9M | $113.8M | $75.53M | $48.52M | $49.25M |
| Total Operating Expenses | $26.75M | $28.11M | $142.5M | $129.4M | $112.1M | $129.7M | $131.6M | $90.85M | $60.40M | $58.49M |
| **Operating Income** | -$26.75M | -$28.11M | -$121.5M | -$87.53M | -$89.08M | $5.38M | -$111.7M | -$77.38M | -$59.48M | -$58.40M |
| **EBITDA** | -$26.65M | -$28.01M | -$121.2M | -$87.29M | -$88.83M | $5.59M | -$111.5M | -$77.01M | -$58.99M | -$56.94M |
| Interest Income | $700K | $700K | -- | -- | -- | -- | -- | -- | -- | -- |
| Income Before Tax | -- | -$71.27M | -$118.5M | -$85.47M | -$88.44M | $7.72M | -$107.2M | -$74.40M | -$58.33M | -$57.75M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | -$691K | -$816K | -$389K | -$204K | -$468K |
| **Net Income** | -$18.21M | -$29.40M | -$118.5M | -$85.47M | -$88.44M | $8.41M | -$106.4M | -$74.01M | -$58.12M | -$57.28M |
| Basic EPS | -$2.46 | -$11.42 | -$944.60 | -$687.77 | -$751.38 | $77.73 | -$1,075.25 | -$889.56 | -$803.20 | -$906.84 |
| **Diluted EPS** | -$3.26 | -$11.42 | -$944.60 | -$687.77 | -$751.38 | $77.73 | -$1,075.25 | -$889.56 | -$803.20 | -$906.84 |
| Basic Shares Outstanding | 7.4M | 2.6M | 125.4K | 124.3K | 117.5K | 109.8K | 98.8K | 83.1K | 72.3K | 63.2K |
| Diluted Shares Outstanding | 7.8M | 2.6M | 125.4K | 124.3K | 117.5K | 111.0K | 98.8K | 83.1K | 72.3K | 63.2K |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | -- | -- | -- | -- | -- | -- | $2.57M | $1.46M |
| Research & Development | $4.47M | $4.00M | $4.91M | $5.49M | $3.60M | $5.81M | $3.11M | $8.60M |
| Total Operating Expenses | $6.33M | $6.63M | $7.05M | $7.59M | $5.94M | $8.87M | $4.35M | $10.80M |
| **Operating Income** | -$6.33M | -$6.63M | -$7.05M | -$7.59M | -$5.94M | -$8.87M | -$4.35M | -$10.80M |
| **EBITDA** | -$6.30M | -$6.61M | -$7.03M | -$7.56M | -$5.91M | -$8.85M | -$4.33M | -$10.78M |
| Interest Income | $200K | $200K | -- | -- | $300K | $100K | -- | -- |
| Interest Expense | -- | -- | -- | -- | $0 | $93K | $558K | -- |
| Income Tax Expense | -- | -- | -- | -- | -- | -- | $0 | $0 |
| **Net Income** | -$6.12M | -$6.46M | -$6.80M | -$7.28M | -$5.53M | $4.17M | -$9.58M | -$12.71M |
| Basic EPS | -$0.48 | -$0.69 | -$0.73 | -- | -$0.59 | $0.51 | -$3.72 | -- |
| **Diluted EPS** | -$0.48 | -$0.69 | -$0.73 | -- | -$0.59 | -$1.00 | -$3.72 | -- |
| Basic Shares Outstanding | 12.7M | 9.4M | 9.4M | -- | 9.4M | 8.2M | 2.6M | -- |
| Diluted Shares Outstanding | 12.7M | 9.4M | 9.4M | -- | 9.4M | 8.5M | 2.6M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $20.73M | $31.61M | $51.77M | $63.74M | $13.45M | $31.68M | $18.30M | $15.08M | $9.39M | $12.09M |
| Short-Term Investments | $10.08M | -- | -- | -- | $153.6M | $149.2M | $136.7M | $146.3M | $83.18M | $46.18M |
| **Cash & Short-Term Investments** | $30.81M | $37.90M | $100.8M | $156.7M | $236.8M | $251.5M | $218.2M | $182.8M | $92.57M | $58.28M |
| Accounts Receivable, Net | -- | $407K | $2.77M | $3.26M | -- | -- | -- | -- | $0 | -- |
| Inventory | -- | $900K | $2.82M | $2.38M | $2.58M | -- | -- | -- | -- | -- |
| **Total Current Assets** | $31.54M | $31.69M | $116.2M | $168.9M | $173.3M | $195.1M | $165.7M | $168.1M | $95.06M | $61.45M |
| Property, Plant & Equipment, Net | $52K | $84K | $3.32M | $426K | $631K | $840K | $700K | $880K | $1.18M | $1.61M |
| Intangible Assets | $322K | $385K | -- | -- | -- | -- | -- | -- | -- | -- |
| Long-Term Investments | -- | -- | -- | -- | $69.75M | $70.56M | $63.16M | $21.40M | -- | -- |
| Other Non-Current Assets | $17K | $17K | -- | -- | -- | -- | -- | -- | -- | -- |
| **Total Non-Current Assets** | $535K | $3.51M | $9.69M | $13.33M | $73.77M | $76.09M | $67.30M | $22.68M | $1.95M | $2.38M |
| **Total Assets** | $32.07M | $35.20M | $125.8M | $182.2M | $247.1M | $271.2M | $233.0M | $190.8M | $97.00M | $63.83M |
| Accounts Payable | $3.22M | $2.19M | $11.58M | $9.60M | $5.62M | $4.89M | $9.10M | $4.37M | $3.83M | $4.74M |
| Deferred Revenue (Current) | -- | -- | -- | -- | -- | -- | $22.26M | $26.82M | -- | -- |
| **Total Current Liabilities** | $11.04M | $10.37M | $25.59M | $23.46M | $17.62M | $18.48M | $42.89M | $40.45M | $8.51M | $11.53M |
| Deferred Revenue (Non-Current) | -- | -- | -- | -- | -- | -- | -- | $15.18M | -- | -- |
| **Total Non-Current Liabilities** | $85K | $30.46M | $43.17M | $0 | $1.92M | $3.67M | $3.35M | $16.75M | $1.72M | $1.57M |
| **Total Liabilities** | $11.13M | $40.83M | $68.76M | $23.46M | $19.53M | $22.16M | $46.25M | $57.19M | $10.22M | $13.10M |
| **Total Debt (incl. Leases)** | $201K | -- | $6.09M | $1.92M | $3.67M | $5.28M | $4.32M | -- | -- | -- |
| Common Stock | $9.0K | $2.0K | $5.0K | $53K | $53K | $50K | $47K | $39K | $33K | $27K |
| Retained Earnings | -$110.5M | -$92.24M | -$684.7M | -$566.2M | -$480.8M | -$392.3M | -$400.7M | -$294.4M | -$220.3M | -$162.2M |
| Accumulated Other Comp. Income | $8.0K | -- | -$260K | -$1.67M | -$358K | $73K | $170K | -$114K | -$70K | $3.0K |
| **Total Stockholders' Equity** | $20.95M | -$91.13M | -$62.06M | $158.8M | $227.5M | $249.0M | $186.7M | $133.6M | $86.78M | $50.73M |
| Total Equity | $20.95M | -$91.13M | -$62.06M | $158.8M | $227.5M | $249.0M | $186.7M | $133.6M | $86.78M | $50.73M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $22.27M | $15.77M | $19.85M | $20.73M | $21.42M | $20.65M | $34.22M | $31.61M |
| Short-Term Investments | $0 | -- | $5.13M | $10.08M | $15.04M | $20.35M | -- | -- |
| **Cash & Short-Term Investments** | $22.27M | $15.77M | $24.98M | $30.81M | $36.46M | $40.99M | $34.22M | $37.90M |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | -- | $1.23M | $407K |
| Inventory | -- | -- | -- | -- | -- | -- | $900K | $900K |
| **Total Current Assets** | $23.13M | $17.07M | $25.33M | $31.54M | $38.44M | $43.13M | -- | $31.69M |
| Property, Plant & Equipment, Net | $28K | $36K | $44K | $52K | $60K | $68K | -- | $84K |
| Intangible Assets | $275K | $291K | $306K | $322K | $338K | $354K | -- | $385K |
| Other Non-Current Assets | $17K | $17K | $17K | $17K | $17K | $17K | -- | $17K |
| **Total Non-Current Assets** | $403K | $448K | $491K | $535K | $578K | $620K | -- | $3.51M |
| **Total Assets** | $23.53M | $17.52M | $25.82M | $32.07M | $39.02M | $43.75M | $38.95M | $35.20M |
| Accounts Payable | $2.08M | $4.64M | $4.62M | $3.22M | $4.08M | $2.42M | $4.0K | $2.19M |
| **Total Current Liabilities** | $8.08M | $9.11M | $11.26M | $11.04M | $11.04M | $10.68M | $1.20M | $10.37M |
| **Total Non-Current Liabilities** | $0 | $22K | $54K | $85K | $115K | $145K | $45.82M | $30.46M |
| **Total Liabilities** | $8.08M | $9.13M | $11.31M | $11.13M | $11.15M | $10.82M | $47.02M | $40.83M |
| **Total Debt (incl. Leases)** | $116K | $145K | $174K | $201K | $228K | $254K | -- | -- |
| Common Stock | $13K | $9.0K | $9.0K | $9.0K | $9.0K | $9.0K | $2.0K | $2.0K |
| Retained Earnings | -$129.8M | -$123.7M | -$117.3M | -$110.5M | -$103.2M | -$97.65M | -$760.5M | -$92.24M |
| Accumulated Other Comp. Income | -- | -- | $1.0K | $8.0K | $7.0K | -$13K | -- | -- |
| **Total Stockholders' Equity** | $15.46M | $8.38M | $14.51M | $20.95M | $27.87M | $32.93M | -$100.6M | -$91.13M |
| Total Equity | $15.46M | $8.38M | $14.51M | $20.95M | $27.87M | $32.93M | -$100.6M | -$91.13M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$18.21M | -$29.40M | -$118.5M | -$85.47M | -$88.44M | $8.41M | -$106.4M | -$74.01M | -$58.12M | -$57.28M |
| Depreciation & Amortization | $95K | $95K | $259K | $248K | $248K | $209K | $198K | $370K | $495K | $1.47M |
| Stock-Based Compensation | $1.40M | $319K | $13.73M | $17.73M | $20.79M | $14.84M | $12.57M | $9.48M | $5.79M | $2.80M |
| Change in Inventory | -- | -$1.04M | -$438K | $201K | -$2.58M | -- | -- | -- | -- | -- |
| **Operating Cash Flow** | -$23.50M | -$18.30M | -$92.08M | -$78.73M | -$60.09M | -$5.49M | -$109.2M | -$22.30M | -$54.83M | -$47.38M |
| Capital Expenditure | -- | -$1.05M | -$2.38M | -$43K | -$39K | -$349K | -$18K | -$73K | -$58K | -$717K |
| **Free Cash Flow** | -- | -$19.35M | -$94.45M | -$78.77M | -$60.13M | -$5.84M | -$109.2M | -$22.37M | -$54.88M | -$48.10M |
| Purchases of Investments | -- | -$32.21M | -$113.6M | -$95.69M | -$208.8M | -$232.9M | -$286.1M | -$337.9M | -$127.4M | -$68.65M |
| Sales & Maturities of Investments | -- | $82.00M | $155.4M | $220.4M | $183.5M | $185.9M | $253.6M | $255.1M | $90.91M | $114.4M |
| **Investing Cash Flow** | -$10.08M | $48.74M | $43.46M | $128.7M | -$4.75M | -$20.27M | -$30.52M | -$82.82M | -$36.50M | $45.02M |
| Common Stock Issued | -- | -- | $1.12M | -- | -- | -- | $136.5M | $92.06M | $86.22M | -- |
| **Financing Cash Flow** | $22.70M | $27.00M | $38.15M | $311K | $46.61M | $39.14M | $142.6M | $110.8M | $87.92M | $123K |
| **Net Change in Cash** | -$10.88M | $8.70M | -$10.47M | $50.29M | -$18.23M | $13.38M | $2.86M | $5.69M | -$2.70M | -$3.01M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$6.12M | -$6.46M | -$6.80M | -$7.28M | -$5.53M | $4.17M | -$9.58M | -$12.71M |
| Depreciation & Amortization | $24K | $23K | $24K | $24K | $24K | $23K | $24K | $24K |
| Stock-Based Compensation | $386K | $335K | $370K | $353K | $339K | $627K | $80K | $79K |
| Change in Inventory | -- | -- | -- | -- | -- | -- | -- | -$729K |
| **Operating Cash Flow** | -$6.38M | -$9.23M | -$5.86M | -$5.68M | -$4.26M | -$5.87M | -$7.69M | -$4.83M |
| Capital Expenditure | -- | -- | -- | -- | -- | -- | -- | $0 |
| **Free Cash Flow** | -- | -- | -- | -- | -- | -- | -- | -$4.83M |
| Purchases of Investments | -- | -- | -- | -- | -- | -- | -- | $0 |
| Sales & Maturities of Investments | -- | -- | -- | -- | -- | -- | -- | $5.00M |
| **Investing Cash Flow** | $0 | $5.14M | $4.98M | $5.00M | $5.35M | -$9.55M | -$10.88M | $5.00M |
| **Financing Cash Flow** | -- | -- | -- | $1.0K | -$322K | $24.63M | -$1.60M | $27.01M |
| **Net Change in Cash** | $6.51M | -$4.09M | -$883K | -$684K | $770K | $9.21M | -$20.18M | -$658K |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | -- | -- | -- | -- | 100.0% | -- | -- | -- | -- | -- |
| **Operating Margin** | -- | -393.8% | -579.4% | -209.1% | -386.8% | 4.0% | -561.6% | -574.5% | -6529.6% | -67907.0% |
| **Net Profit Margin** | -- | -411.9% | -565.2% | -204.2% | -384.1% | 6.2% | -534.9% | -549.5% | -6380.4% | -66604.7% |
| Return on Equity (ROE) | -87.0% | -- | -- | -53.8% | -38.9% | 3.4% | -57.0% | -55.4% | -67.0% | -112.9% |
| Return on Assets (ROA) | -56.8% | -83.5% | -94.2% | -46.9% | -35.8% | 3.1% | -45.7% | -38.8% | -59.9% | -89.7% |
| Current Ratio | 2.86x | 3.06x | 4.54x | 7.20x | 9.84x | 10.55x | 3.86x | 4.16x | 11.18x | 5.33x |
| Quick Ratio | 2.79x | 2.97x | 4.43x | 7.10x | 9.69x | 13.61x | 5.09x | 4.52x | 10.88x | 5.05x |
| Debt to Equity | 0.01x | -- | -- | 0.01x | 0.02x | 0.02x | 0.02x | -- | -- | -- |
| **Revenue Growth (YoY)** | -- | -66.0% | -49.9% | +81.8% | -83.0% | +579.3% | +47.6% | +1378.5% | +959.3% | -97.7% |
| Operating Income Growth (YoY) | -- | -- | -- | -- | -1754.3% | -- | -- | -- | -- | -- |
| **Net Income Growth (YoY)** | -- | -- | -- | -- | -1151.6% | -- | -- | -- | -- | -- |
| EPS Growth (YoY) | -- | -- | -- | -- | -1066.7% | -- | -- | -- | -- | -- |
| 5Y Revenue / Share Growth | -- | -98.6% | +3.1% | +2571.6% | +14301.9% | +1744.4% | +207.6% | -87.0% | -91.9% | -- |
| 10Y Revenue / Share Growth | -- | -95.8% | -86.6% | +116.3% | -- | -- | -- | -- | -- | -- |
| 5Y Net Income / Share Growth | -103.2% | -- | -- | -- | -- | -- | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -- | -- | -- | -- | -- | -- | -370.0% | -747.2% |
| **Net Profit Margin** | -- | -- | -- | -- | -- | -- | -459.3% | -411.9% |
| Return on Equity (ROE) | -172.5% | -310.9% | -106.4% | -87.0% | -84.9% | -71.8% | -- | -- |
| Return on Assets (ROA) | -113.3% | -148.8% | -59.8% | -56.8% | -60.6% | -54.0% | -89.3% | -83.5% |
| Current Ratio | 2.86x | 1.87x | 2.25x | 2.86x | 3.48x | 4.04x | -- | 3.06x |
| Quick Ratio | 2.76x | 1.73x | 2.22x | 2.79x | 3.30x | 3.84x | 29.56x | 2.97x |
| Debt to Equity | 0.01x | 0.02x | 0.01x | 0.01x | 0.01x | 0.01x | -- | -- |
| **Revenue Growth (YoY)** | -- | -- | -- | -- | -- | -- | +20.3% | -51.6% |
| **Net Income Growth (YoY)** | -- | -255.0% | -- | -- | -- | -- | -- | -- |
| EPS Growth (YoY) | -- | -235.3% | -- | -- | -- | -- | -- | -- |
| Operating Cash Flow Growth (YoY) | -- | -- | -- | -- | -- | -124.8% | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
